The "why" part to that—well, that's probably multi-factorial, we know from the interim report, where Pharmac was described as having a fortress mentality. It's not prepared to share information and, in fact, it wasn't even prepared to share with the review panel. It's a problem, which, again, is highlighted in today's Pharmac report. Secondly, it's pointed out today that they don't well incorporate the consumer voice, so much so that their clinical advisory committees, which includes the Pharmacology and Therapeutics Advisory Committee, are being reconfigured, and, instead of being internal assignments, are actually going to be ministerially appointed.